Menene SAM-e (S-adenosylmethionine)?

SAM-e May Yayi Amfani da Osteoarthritis da Matsanancin ciki

Hype da gargadi sukan yadu a kusa da abin da ake ci. SAM-e (S-adenosylmethionine) yana daga cikin abubuwan da ke cike da abincin da suke da'awar cewa suna da tasiri masu amfani don zalunta osteoarthritis da ciki.

Menene SAM-e?

Sam-e (S-adenosylmethionine) ba magani ne na dabba ba , amma wani fili ne wanda jikinmu ke samarwa daga methionine, amino acid wanda ke samo abinci mai gina jiki.

A matsayin kari, an yi SAM-e ne daga yisti mai yisti ko gaba ɗaya.

Yaya SAM-e ke aiki?

Tare da ƙarin taimako daga bitamin B-12 da kuma folic acid, SAM-e na barin ƙungiyar methyl daga abun da ke ciki zuwa zane-zane da gabobin da ke kewaye. Ta hanyar wannan aikin, SAM-e yana taimakawa tare da kiyaye ƙwayoyin salula, kawar da abubuwa masu guba daga jiki, da kuma samar da na'urori masu kwakwalwa.

Bugu da ƙari, SAM-e ya bayyana ya tsara fiye da 35 hanyoyin daban-daban. Da rashin lafiya na SAM-e, wasu kwayoyin sunana suna da tsabta wanda zai iya taimakawa wajen haɗin gwiwar haɗi . An yi tunanin cewa SAM-e ƙara ƙwayoyin da ke haɗuwa da guringuntsi (wanda aka sani da chondrocytes), yana shafar fureti, kuma yana iya rage lalacewar chondrocytes.

Ta yaya aka gano SAM-e?

An yi amfani da SAM-e shekaru da yawa a Turai don magance cututtukan zuciya da kuma ciwo. An gano abu a cikin shekarun 1950 a Makarantun Lafiya na kasa.

A cikin shekarun 1970s, bayan da Labarin Italiyanci ya koyi don samar da ita a al'amuran salula, an bincike SAM-e a matsayin mai cike da damuwa. Wasu daga cikin marasa lafiya na farko wadanda aka bai wa SAM-e saboda rashin ciki sun sha wahala tare da osteoarthritis. Samun da aka samu na SAM-e wanda aka samo asali ne a yayin da wadannan marasa lafiya suka ba da rahoto daga jin dadin su, tare da bakin ciki.

Harkokin maganin arthritic ya nuna cewa SAM-e na iya taimakawa da ƙarfi da kumburi, da kuma ciwo. Zai iya inganta motsi saboda haka. Yana iya taimakawa bayyanar cututtuka na fibromyalgia , bursitis , da tendinitis, da ciwo mai rauni, da kuma bayar da sakamako masu amfani ga osteoarthritis.

Menene Nazarin Ya Bayyana?

Magunguna na Arthritis sun shiga cikin binciken da aka kwatanta da SAM-e zuwa placebo ko wasu NSAID (magungunan marasa lafiya na steroidal) . A cikin zane-zane, wanda aka wallafa a cikin Journal of Practice Family, Mayu 2002, marasa lafiya SAM-e sun sami taimako sosai kamar yadda marasa lafiya ke daukar NSAIDs. A wani gwaji (BMC Cutar Musculoskeletal 2004), wanda ya kasance gwajin da aka samu idan aka kwatanta da miliyon 1600 na SAM-e zuwa 200 m Celebrex (celecoxib) na tsawon makonni 16, an kammala cewa SAM-e ya yi aiki da hankali amma yana da tasiri a matsayin Celebrex lokaci don gwiwa osteoarthritis. Babu tsare-tsaren da ke faruwa a yanzu don gudanar da nazarin karatun wuribo a Amurka wanda wajibi ne don tabbatar da tasirin magungunan.

Shin akwai wani dangantaka da aka haɗa da SAM-e?

Halin da aka saba sabawa na Sam-e don osteoarthritis shine 600 zuwa 1,200 MG kowace rana. Akwai yiwuwar sakamako mai lalacewa, tare da yiwuwar mummunan tasiri a mafi asara.

Hanyoyi masu illa zasu iya haɗuwa da laushi, flatulence, zawo, da ciwon kai.

Layin Ƙasa

An sayar da SAM-e a matsayin ƙarin kariyar Amurka a Amurka. A Turai, ana sayar da shi ta takardar sayan magani. Kamfanin sayar da kasuwancin yana nuna cewa yana inganta "lafiyar haɗin gwiwa" da kuma "zaman lafiya". Gidajen Abincin da Drug, wanda ke kula da kasuwannin abincin abincin abincin, ba ya yarda da ƙwayar likita game da marufi na kari.

Sources:

SAM-e. Jagoran Bayanin Arthritis Today. Arthritis Foundation. Samun shiga 01/30/2016.
http://www.arthritis.org/living-with-arthritis/treatments/natural/supplements-herbs/guide/sam-e.php

Tsaro da ingancin S-adenosylmethionine (SAM-e) don osteoarthritis. Soeken KL et al. Jaridar Ayyukan Iyali. Mayu 2002.
http://www.ncbi.nlm.nih.gov/pubmed/12019049

S-Adenosyl methionine (SAM-e) game da celecoxib don maganin osteoarthritis bayyanar cututtuka: Hanyar kaifi guda biyu a kan fitinar. BMC Cutar Musculoskeletal. Wadie Na Najm et al. Fabrairu 2004.
http://www.biomedcentral.com/1471-2474/5/6

Cowley, Geoffrey. Maris 22, 1999. "Sammy Solution". Newsweek 133 (12): 65.